Literature DB >> 23686042

A kind of D-amino acid oxidase inhibitor, sodium benzoate, might relieve panic symptoms in a first-episode, drug-naïve panic-disorder patient.

Yi-Cheng Hou, Chien-Han Lai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23686042     DOI： 10.1176/appi.neuropsych.12030075

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  2 in total

Review 1.  Sodium Benzoate-Harmfulness and Potential Use in Therapies for Disorders Related to the Nervous System: A Review.

Authors:  Łucja Justyna Walczak-Nowicka; Mariola Herbet
Journal:  Nutrients       Date:  2022-04-02       Impact factor: 5.717

2.  The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.

Authors:  Alex Ryan; Andrea Baker; Frances Dark; Sharon Foley; Anne Gordon; Sean Hatherill; Stephen Stathis; Sukanta Saha; George Bruxner; Martin Beckman; Drew Richardson; Michael Berk; Olivia Dean; John McGrath; Cadence Working Group; James Scott
Journal:  Trials       Date:  2017-04-07       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.